Top Markets
#1 ADO Protocol ADO Protocol +336.33%
#2 Islamic Coin Islamic Coin +155.40%
#3 GoPlus Security GoPlus Security +51.61%
#4 Starpower Starpower +33.70%
#5 GAIB AID GAIB AID +24.67%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.27%
#7 The Black Bull The Black Bull +15.49%
#8 Nockchain Nockchain +14.55%
#9 XMAQUINA XMAQUINA +12.20%
#10 Casper Network Casper Network +11.65%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

CUPR
Rank in Stocks #33381
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical... Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.
Share Price
$3.02
Market Cap
$8.10M
Change (1 day)
0.33%
Change (1 year)
-68.28%
Country
SG
Trade Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

Category

Healthcare
Earnings for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)
Earnings in 2026 TTM: 0
According to Cuprina Holdings (Cayman) Limited Class A Ordinary Shares latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE